MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 89 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $17,491,000 | +133.9% | 14,106 | +481.0% | 0.00% | – |
Q1 2017 | $7,478,000 | -78.7% | 2,428 | -71.8% | 0.00% | – |
Q4 2016 | $35,129,000 | -45.6% | 8,610 | -15.3% | 0.00% | – |
Q3 2016 | $64,522,000 | +152.5% | 10,161 | +114.4% | 0.00% | – |
Q2 2016 | $25,549,000 | -87.2% | 4,740 | -81.2% | 0.00% | – |
Q4 2015 | $198,954,000 | +2.1% | 25,184 | +10.0% | 0.00% | – |
Q3 2015 | $194,879,000 | +72.3% | 22,900 | +150.2% | 0.00% | – |
Q2 2015 | $113,131,000 | +309.4% | 9,153 | +293.5% | 0.00% | – |
Q1 2015 | $27,633,000 | -46.6% | 2,326 | -60.5% | 0.00% | – |
Q3 2014 | $51,723,000 | +2490.0% | 5,891 | +2050.0% | 0.00% | – |
Q2 2014 | $1,997,000 | -63.7% | 274 | -78.1% | 0.00% | – |
Q1 2014 | $5,501,000 | -17.8% | 1,253 | 0.0% | 0.00% | – |
Q4 2013 | $6,691,000 | -93.2% | 1,253 | -95.2% | 0.00% | – |
Q3 2013 | $98,714,000 | -59.5% | 26,046 | -28.1% | 0.00% | – |
Q2 2013 | $243,929,000 | – | 36,245 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|